SQZ Biotechnologies Company

OTCPK:SQZB Stock Report

Market Cap: US$1.4m

SQZ Biotechnologies Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for SQZ Biotechnologies.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth23.2%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

Jun 26
SQZ Biotechnologies Company (NYSE:SQZ) Might Not Be As Mispriced As It Looks After Plunging 30%

We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

Jan 05
We Think SQZ Biotechnologies (NYSE:SQZ) Needs To Drive Business Growth Carefully

SQZ Biotechnologies GAAP EPS of -$0.77 beats by $0.06, revenue of $3.5M misses by $0.76M

Nov 09

SQZ Biotech spikes as H.C. Wainwright initiates with Buy citing platform technology

Oct 20

Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

Aug 20
Is SQZ Biotechnologies (NYSE:SQZ) In A Good Position To Deliver On Growth Plans?

SQZ Biotechnologies GAAP EPS of -$0.78 misses by $0.01, revenue of $3.22M misses by $0.97M

Aug 04

SQZ Biotechnologies names business chief as CFO

Jul 11

Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

May 17
Time To Worry? Analysts Just Downgraded Their SQZ Biotechnologies Company (NYSE:SQZ) Outlook

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

May 02
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Jan 11
Here's Why We're Watching SQZ Biotechnologies' (NYSE:SQZ) Cash Burn Situation

Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Jul 30
Will SQZ Biotechnologies (NYSE:SQZ) Spend Its Cash Wisely?

Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

May 16
Need To Know: Analysts Are Much More Bullish On SQZ Biotechnologies Company (NYSE:SQZ)

Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

Mar 25
Newsflash: SQZ Biotechnologies Company (NYSE:SQZ) Analysts Have Been Trimming Their Revenue Forecasts

SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Mar 20
SQZ Biotechnologies Company (NYSE:SQZ) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

Feb 01
We Think SQZ Biotechnologies (NYSE:SQZ) Can Afford To Drive Business Growth

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SQZ Biotechnologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:SQZB - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202312-72-75-74N/A
6/30/202316-71-82-82N/A
3/31/202319-76-87-87N/A
12/31/202221-79-84-84N/A
9/30/202222-78-84-84N/A
6/30/202223-78-83-83N/A
3/31/202225-74-83-82N/A
12/31/202127-69-83-82N/A
9/30/202117-75-81-80N/A
6/30/202119-64-75-75N/A
3/31/202120-55-68-67N/A
12/31/202021-51-44-43N/A
9/30/202025-43-35-33N/A
6/30/202023-39-35-33N/A
3/31/202021-37-21-20N/A
12/31/201920-32-36-33N/A
12/31/201813-202021N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SQZB's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if SQZB's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if SQZB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SQZB's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if SQZB's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if SQZB's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.